Cerity Partners
THC icon

Cerity Partners’s Tenet Healthcare THC Stock Holding History

Cerity Partners’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24M Sell
128,022
-19,633
-13% -$3.61M 0.03% 425
2026
Q1 		$27.9M Sell
147,655
-8,486
-5% -$1.79M 0.04% 356
2025
Q4 		$31M Buy
156,141
+12,060
+8% +$2.44M 0.05% 312
2025
Q3 		$29.3M Buy
144,081
+23,458
+19% +$4.16M 0.05% 306
2025
Q2 		$21.2M Buy
120,623
+11,395
+10% +$1.72M 0.04% 348
2025
Q1 		$14.7M Buy
109,228
+84,309
+338% +$11.1M 0.03% 401
2024
Q4 		$3.28M Sell
24,919
-6,137
-20% -$913K 0.01% 888
2024
Q3 		$5.16M Buy
31,056
+12,480
+67% +$1.89M 0.01% 686
2024
Q2 		$2.47M Buy
18,576
+10,341
+126% +$1.24M 0.01% 827
2024
Q1 		$866K Buy
8,235
+3,421
+71% +$307K ﹤0.01% 1345
2023
Q4 		$364K Sell
4,814
-6,228
-56% -$395K ﹤0.01% 1422
2023
Q3 		$728K Buy
+11,042
New +$826K ﹤0.01% 852
2023
Q2 		– Sell
-4,942
Closed -$294K – 1940
2023
Q1 		$294K Buy
4,942
+89
+2% +$4.95K ﹤0.01% 1538
2022
Q4 		$237K Buy
+4,853
New +$224K ﹤0.01% 1245
2022
Q1 		– Sell
-2,540
Closed -$207K – 1106
2021
Q4 		$207K Buy
+2,540
New +$186K ﹤0.01% 923

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Cerity Partners's THC Position: Q2 2026 in Review

Cerity Partners reduced its Tenet Healthcare (THC) stake by 13% in Q2 2026, selling an estimated $3.61M and leaving 128,022 shares worth $24M. The position accounts for 0.03% of the portfolio, ranked #425.

Cerity Partners first reported a position in THC in Q4 2021 and has held it in 15 quarters since. The position peaked at $31M in Q4 2025. 628 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Cerity Partners held 128,022 shares of Tenet Healthcare worth $24M as of Q2 2026.
  • Cerity Partners sold 19,633 Tenet Healthcare shares in Q2 2026, an estimated $3.61M.
  • Tenet Healthcare made up 0.03% of Cerity Partners's portfolio in Q2 2026, its #425 holding.
  • Cerity Partners first reported a position in Tenet Healthcare in Q4 2021 and has held it in 15 quarters since.
  • Cerity Partners's Tenet Healthcare position peaked at $31M in Q4 2025.
  • 628 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.